Galectin-9、Cadherin-11在胰腺癌组织中的表达及其与临床病理特征及预后的关系OACSTPCD
Expression of Galectin-9 and Cadherin-11 in pancreatic cancer and their relationship with clinicopathological features and prognosis
目的 探讨胰腺癌组织中半乳糖凝集素-9(Galectin-9)、钙黏蛋白-11(Cadherin-11)蛋白表达及其与患者临床病理特征、预后的关系.方法 收集2019年1月至2021年12月商洛职业技术学院附属医院107例胰腺癌患者癌组织及癌旁组织标本,采用免疫组织化学法检测Galectin-9、Cadherin-11的表达,并分析癌组织中Galectin-9、Cadherin-11表达与临床病理特征的关系;采用Kaplan-Meier生存曲线分…查看全部>>
Objective To investigate the expression of Galectin-9 and Cadherin-11 in pancreatic cancer and their relationship with clinicopathological features and prognosis.Methods A total of 107 cases of pancreatic cancer tissues and adjacent tissues were collected from the Affiliated Hospital of Shangluo Vocational and Technical College from January 2019 to December 2021.The expression of Galectin-9 and Cadherin-11 was de-tected by immunohistochemistry.The relationsh…查看全部>>
童小华;王菁菁
商洛职业技术学院附属医院/商洛国际医学中心医院病理科,陕西商洛 726000陕西省安康市中心医院感控科,陕西安康 725000
临床医学
胰腺癌半乳糖凝集素-9钙黏蛋白-11临床病理特征预后
pancreatic cancerGalectin-9Cadherin-11clinical pathology featureprognosis
《检验医学与临床》 2024 (2)
232-236,5
评论